Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis C Virus Chronic Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT02804386
What this trial is testing

Efficacy and Safety of Zoval (Sofosbuvir) and Ribavirin With or Without Interferon

Who this might be right for
Hepatitis C, Chronic
PharmEvo Pvt Ltd 573
Not applicableStudy completedNCT02537379
What this trial is testing

Use-Results Surveillance Study of Sovaldi® Plus Copegus® in Japanese Patients With Chronic Genotype 2 Hepatitis C Virus Infection

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 552
Large-scale testing (Phase 3)Study completedNCT02247401
What this trial is testing

Coadministration of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) With Ribavirin (RBV) in Adults With Genotype 4 (GT4) Hepatitis C Virus (HCV) in Egypt

Who this might be right for
HCVHepatitis C InfectionGenotype 4
AbbVie 160
Post-approval studies (Phase 4)Ended earlyNCT00255034
What this trial is testing

Effects of 48 Weeks Versus 24 Weeks of Therapy With Peg-Intron/Ribavirin in Patients With Chronic Hepatitis C, Genotype 3 (Study P04143)(TERMINATED)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 146
Testing effectiveness (Phase 2)Study completedNCT02421211
What this trial is testing

Investigate the Pharmacokinetic Interactions Between Simeprevir and Ledipasvir in a Treatment Regimen Consisting of Simeprevir, Sofosbuvir, and Ledipasvir in Treatment-naive Participants With Chronic Hepatitis C Virus Genotype 1 Infection

Who this might be right for
Hepatitis C, Chronic
Janssen Sciences Ireland UC 41
Post-approval studies (Phase 4)Study completedNCT00830609
What this trial is testing

High Dose Versus Standard Dose of Ribavirin in Patients With Chronic Hepatitis C, Genotype 3

Who this might be right for
Chronic Hepatitis C
Dr. Conrado Fernandez 101
Large-scale testing (Phase 3)Ended earlyNCT02319200
What this trial is testing

Primary Prevention Hepatocellular Carcinoma by Metformin

Who this might be right for
Hepatocellular CarcinomaHepatitis C, ChronicCirrhosis
Assistance Publique - Hôpitaux de Paris 11
Testing effectiveness (Phase 2)Study completedNCT00787371
What this trial is testing

Effect of Low-dose PegIntron on ALT Normalization in Japanese Patients With Chronic Hepatitis C (Study P04508)(COMPLETED)

Who this might be right for
Hepatitis C, ChronicHepatitis C
Merck Sharp & Dohme LLC 69
Testing effectiveness (Phase 2)Study completedNCT02457611
What this trial is testing

Safety and Efficacy of Ledipasvir/Sofosbuvir (LDV/SOF) Fixed-Dose Combination (FDC) for 6 Weeks in Adults With Acute Genotype 1 or 4 Hepatitis C Virus (HCV) and Chronic Human Immunodeficiency Virus (HIV)-1 Co-Infection

Who this might be right for
Hepatitis C Infection With HIV Co-Infection
Gilead Sciences 26
Post-approval studies (Phase 4)Study completedNCT00686777
What this trial is testing

Pegylated Interferon (PEG-IFN) Alfa-2b and Low Dose Ribavirin for the Treatment of Chronic Hepatitis C Patients With Genotype 1 High Viral Load and Low Body Weight (Study P05172)(COMPLETED)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 75
Testing effectiveness (Phase 2)Study completedNCT00743795
What this trial is testing

Safety, Tolerability, and Antiviral Activity of 24 or 48 Weeks of GS-9190 in Combination With Peginterferon Alfa 2a and Ribavirin for the Treatment of Genotype-1 Chronic HCV Infection

Who this might be right for
HCV Infection
Gilead Sciences 252
Not applicableUnknownNCT04585165
What this trial is testing

User-friendly HIV Testing and Counseling Services

Who this might be right for
HIV InfectionsSexually Transmitted InfectionHepatitis B, Chronic+1 more
Institut de Recherche pour le Developpement 3,000
Testing effectiveness (Phase 2)Study completedNCT02133131
What this trial is testing

Efficacy and Safety of Grazoprevir (MK-5172), Elbasvir (MK-8742), and Sofosbuvir for Chronic Infection With Hepatitis C Virus Genotypes 1 and 3 (MK-5172-074)

Who this might be right for
Hepatitis C
Merck Sharp & Dohme LLC 143
Not applicableStudy completedNCT02943330
What this trial is testing

Depression, Genes, Cytokines, Chronic Fatigue, Physical Illnesses and Quality of Life

Who this might be right for
HemodialysisHepatitis C
Chang Gung Memorial Hospital 170
Early research (Phase 1)WithdrawnNCT00956722
What this trial is testing

Hyperimmune Bovine Colostrum - TRAVELAN™ for Patients With Chronic Hepatitis C Virus Infection Not Responding to Standard Therapy

Who this might be right for
Asymptomatic Chronic HCV Carriers
Hadassah Medical Organization
Large-scale testing (Phase 3)Study completedNCT02114177
What this trial is testing

Efficacy and Safety Study of Simeprevir in Combination With Sofosbuvir in Participants With Chronic Hepatitis C Virus Infection Without Cirrhosis

Who this might be right for
Hepatitis C Virus Infection
Janssen Infectious Diseases BVBA 310
Not applicableStudy completedNCT01335230
What this trial is testing

The Study of Gut Associated Lymphocytes in HIV and HCV/HIV Co-infected Patients

Who this might be right for
HIVHepatitis C, ChronicHCV Coinfection
University of Cincinnati 40
Not applicableStudy completedNCT01850745
What this trial is testing

Multidisciplinary Support Program in Chronic Hepatitis C

Who this might be right for
Hepatitis C, Chronic
Parc de Salut Mar 447
Early research (Phase 1)Study completedNCT01337375
What this trial is testing

The Pharmacokinetics And Pharmacodynamics of Intravenously Administered Pegasys (Peginterferon Alfa-2a) in Patients With Chronic Hepatitis C And Previous Non-Response to Pegylated Interferon And Ribavirin Combination Therapy

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 31
Not applicableStudy completedNCT04202081
What this trial is testing

Voices From the Black Community: Hepatitis C Research Participation

Who this might be right for
Hepatitis C, Chronic
University of North Carolina, Chapel Hill 200
Next Page